Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to welcome Dr James G. Wright to NDORMS, as Senior Clinical Research Fellow focusing on Paediatric Orthopaedics and Evidence-based Orthopaedics.

We are delighted to welcome Dr James G. Wright to NDORMS, as Senior Clinical Research Fellow focusing on Paediatric Orthopaedics and Evidence-based Orthopaedics.

A prominent orthopaedic surgeon, former Vice President Medical, Surgeon in Chief and Chief of Perioperative Services at the Hospital for Sick Children in Toronto, Canada, Dr Wright has a strong commitment to research with more than 230 peer-reviewed publications, including Lancet, Science, New England Journal of Medicine, Journal of the American Medical Association, and the British Medical Journal. Dr.  Wright has, for the past 15 years, held the Robert B. Salter Chair of Paediatric Surgical Research, awarded to outstanding individuals who are responsible for world-leading research and academic activities in their fields.

As Senior Scientist in the Child Health Evaluative Sciences Program in The SickKids Research Institute (a program he previously led for 5 years), his research has focused on the development of measures to evaluate surgical therapy, randomised clinical trials, and evaluating unmet need and disparity in the use of orthopaedic procedures.

Dr. Wright is also an advocate for better medical education; in 1997, he won the Robert B. Salter Excellence in Orthopaedic Education Award and is active in both graduate student and medical education.

Speaking of his move to Oxford, Dr Wright says: “I have long admired and am thrilled by the opportunity to join the distinguished and world-renowned clinical and research faculty at the University of Oxford. I am excited to use Oxford as center for pediatric orthopedic clinical trials and to work with the well-established research group to tackle the next challenge beyond evidence based orthopaedics, changing surgeon behaviour.”

Head of Department Professor Andrew Carr said: “I am delighted that Professor Wright is moving to Oxford. He has an international reputation as an inspirational leader in his field. His clinical and research expertise will be a valuable addition to programmes in clinical trials and paediatric orthopaedics.”

Similar stories

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

Vascular loss shown to be the primary hallmark of aging

Kennedy Main Tissue remodelling and regeneration

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.

Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain

Botnar Main Research Statistics and epidemiology

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.